- LatestEthiopian activist honoured for 97% FGM reduction
- Latest2,000 Malagasy women 'develop fistula each year'
- LatestHip-hop artist warns Senegal pupils about FGM
- LatestStrengthening Midwifery Care – Global Symposium (26-27 May 2013)
- LatestNew to download: FIGO Newsletter, May 2013
- Latest‘Midwives key in the fight against maternal and newborn morbidity and mortality’
Menopausal women 'still unsure about hormone therapy'
New research suggests that the majority of women approaching the menopause are worried about the risks associated with hormone therapies, but are reluctant to discuss the treatment options available to them with their doctors.
A US-based survey conducted by the Endocrine Society revealed that 62 per cent of menopausal women have never discussed hormone therapy with their primary care provider and 49 per cent have a negative impression of the treatment.
In 2002, a comprehensive US government-funded study called the Women's Health Initiative reported that hormone therapy - specifically the combination of oestrogen and progestin together - increased the risk of blood clots, strokes, breast cancer and heart attacks.
Since then, additional research has indicated the level of risk depends on the individual patient, with her medical history, age and the number of years since her menopause began all being significant.
"Women deserve some clear answers and helpful tools to engage their doctors in meaningful conversations about the multiple choices available to improve their menopausal symptoms," said Cynthia Stuenkel, an endocrinologist specialising in menopause at the University of California, San Diego.
Posted by Alexandra George
World Congress 2015